Semaglutide Sublingually: Clinical Approaches, Marketing, Compliance & SubMagna™
PCCA Products
•
1h 29m
For pharmacies performing nonsterile compounding, USP 795 is no longer optional. In many states, it’s now mandatory; and where it isn’t yet, it remains the best practice standard for compounding in a way that best protects patient and compounder safety.
Tackle the biggest and easiest-to-miss challenges of maintaining annual USP compliance for training staffs as large as 50+ compounders or as self-reliant as a self-owned and solo-staffed community pharmacy. Join our upcoming free webinar to learn how your team can use eLearning Compounding Training & Learning Management System to achieve annual USP compliance in training and competencies with insights on:
• Frequent USP application missteps and how to avoid them
• The role of your designated persons
• Consistency in compounding with competencies
• Long-term compliance planning
• And more!
Up Next in PCCA Products
-
Introducing SubMagna™ SL HMW, PCCA's ...
The wait is over! Join PCCA Director of Research & Development Daniel Banov, RPh, to learn the science behind our newest base – SubMagna™ SL HMW.
Developed to provide an alternative dosing delivery system for commercially available semaglutide, tirzepatide and a broad range of other APIs, this b...
-
Navigating the Lab with Methylene Blu...
Learn best practices that can enhance your experience compounding with methylene blue. Senior Formulations Specialist Stacey Lemus, BS, will present techniques developed by our Formulations teams in lab that can ease the sometimes stressful process of working with this vibrant API. This webinar i...
-
Drive Pharmacy Growth
Are you looking to drive growth in your compounding pharmacy?
Join us for this FREE webinar, led by PCCA Director of Business Solutions Laura Pfaffenberger, PharmD, that will equip you with actionable strategies and essential tools to boost patient outcomes, enhance prescriber relationships, eng...
